China
# |
Name |
Interest Coverage Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
42,652.03
|
Dec. 31, 2023 | USD 2.82 | 2.48% |
|
China |
|
2 |
15,582.15
|
Dec. 31, 2023 | USD 6.64 | 6.03% |
|
China |
|
3 |
12,204.38
|
Dec. 31, 2023 | USD 2.64 | 3.93% |
|
China |
|
4 |
11,387.21
|
Dec. 31, 2023 | USD 2.61 | 3.57% |
|
China |
|
5 |
7,733.58
|
Dec. 31, 2023 | USD 2.60 | 1.18% |
|
China |
|
6 |
6,847.18
|
Dec. 31, 2023 | USD 1.04 | 1.87% |
|
China |
|
7 |
4,813.99
|
Dec. 31, 2023 | USD 0.94 | 3.63% |
|
China |
|
8 |
3,185.27
|
Dec. 31, 2023 | USD 8.73 | 8.10% |
|
China |
|
9 |
3,102.99
|
Dec. 31, 2023 | USD 1.76 | 3.79% |
|
China |
|
10 |
1,801.08
|
Dec. 31, 2023 | USD 3.27 | 2.18% |
|
China |
|
11 |
1,243.91
|
Dec. 31, 2023 | USD 3.74 | 2.82% |
|
China |
|
12 |
1,243.47
|
Dec. 31, 2023 | USD 1.15 | 2.95% |
|
China |
|
13 |
915.13
|
Dec. 31, 2023 | USD 0.89 | 2.52% |
|
China |
|
14 |
904.08
|
Dec. 31, 2023 | USD 0.72 | 5.40% |
|
China |
|
15 |
902.84
|
Dec. 31, 2023 | USD 23.99 | 3.90% |
|
China |
|
16 |
817.74
|
Dec. 31, 2023 | USD 9.77 | 0.05% |
|
China |
|
17 |
728.77
|
Dec. 31, 2023 | USD 8.51 | 2.10% |
|
China |
|
18 |
713.19
|
Dec. 31, 2023 | USD 6.04 | 3.46% |
|
China |
|
19 |
668.39
|
Dec. 31, 2023 | USD 2.28 | 6.43% |
|
China |
|
20 |
649.59
|
Dec. 31, 2023 | USD 3.24 | 2.11% |
|
China |
|
21 |
631.84
|
Dec. 31, 2023 | USD 1.34 | 5.04% |
|
China |
|
22 |
582.41
|
Dec. 31, 2023 | USD 4.94 | 3.02% |
|
China |
|
23 |
442.84
|
Dec. 31, 2023 | USD 3.99 | 1.96% |
|
China |
|
24 |
405.84
|
Dec. 31, 2023 | USD 10.09 | 5.71% |
|
China |
|
25 |
395.10
|
Dec. 31, 2023 | USD 1.55 | 3.64% |
|
China |
|
26 |
385.08
|
Dec. 31, 2023 | USD 7.16 | 2.79% |
|
China |
|
27 |
343.54
|
Dec. 31, 2023 | USD 8.44 | 1.77% |
|
China |
|
28 |
317.29
|
Dec. 31, 2023 | USD 15.35 | 4.46% |
|
China |
|
29 |
313.48
|
Dec. 31, 2023 | USD 1.14 | 2.84% |
|
China |
|
30 |
300.30
|
Dec. 31, 2023 | USD 2.65 | 1.42% |
|
China |
|
31 |
269.37
|
Dec. 31, 2023 | USD 0.92 | 3.55% |
|
China |
|
32 |
260.08
|
Dec. 31, 2023 | USD 0.88 | 4.38% |
|
China |
|
33 |
244.19
|
Dec. 31, 2023 | USD 0.17 | 1.49% |
|
China |
|
34 |
238.09
|
Dec. 31, 2023 | USD 2.64 | 3.21% |
|
China |
|
35 |
227.23
|
Dec. 31, 2023 | USD 5.86 | 3.13% |
|
China |
|
36 |
215.40
|
Dec. 31, 2023 | USD 2.72 | 2.05% |
|
China |
|
37 |
206.45
|
Dec. 31, 2023 | USD 2.89 | 3.83% |
|
China |
|
38 |
204.28
|
Dec. 31, 2023 | USD 9.47 | 1.45% |
|
China |
|
39 |
202.59
|
Dec. 31, 2023 | USD 1.73 | 3.61% |
|
China |
|
40 |
190.06
|
Dec. 31, 2023 | USD 1.05 | 3.24% |
|
China |
|
41 |
188.95
|
Dec. 31, 2023 | USD 1.84 | 3.23% |
|
China |
|
42 |
188.71
|
Dec. 31, 2023 | USD 2.96 | 2.80% |
|
China |
|
43 |
184.99
|
Dec. 31, 2023 | USD 2.32 | 4.82% |
|
China |
|
44 |
173.97
|
Dec. 31, 2023 | USD 1.61 | 2.71% |
|
China |
|
45 |
164.47
|
Dec. 31, 2023 | USD 2.46 | 5.25% |
|
China |
|
46 |
163.08
|
Dec. 31, 2023 | USD 1.59 | 4.31% |
|
China |
|
47 |
158.85
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
48 |
157.30
|
Dec. 31, 2023 | USD 2.17 | 2.25% |
|
China |
|
49 |
154.65
|
Dec. 31, 2023 | USD 2.98 | 1.97% |
|
China |
|
50 |
148.25
|
Dec. 31, 2023 | USD 1.06 | 2.98% |
|
China |
The Biotechnology company in China with the highest Interest Coverage Ratio is Yantai Zhenghai Biotechnology Co., Ltd. (Shenzhen Stock Exchange: 300653.SZ) at 42,652.03.
The Biotechnology company in China with the lowest Interest Coverage Ratio is HighTide Therapeutics Inc (HKSE: 2511.HK) at -2,403.14.
The top 10 Biotechnology companies in China by Interest Coverage Ratio are Yantai Zhenghai Biotechnology Co., Ltd., Giant Biogene Holding Co., Ltd., Vcanbio Cell & Gene Engineering Corp., Ltd, Caina Technology Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd, Beijing SL Pharmaceutical Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Shanghai Allist Pharmaceuticals Co., Ltd., Zhejiang Xinguang Pharmaceutical Co., Ltd. and Beijing Succeeder Technology Inc..
The bottom 10 Biotechnology companies in China by Interest Coverage Ratio are HighTide Therapeutics Inc, Ascletis Pharma Inc., Beijing Science Sun Pharmaceutical Co., Ltd., Cutia Therapeutics, MicroTech Medical (Hangzhou) Co., Ltd., Shanghai Bio-heart Biological Technology Co., Ltd., Shandong Sanyuan Biotechnology Co.,Ltd., Shanghai ZJ Bio-Tech Co., Ltd., Staidson (Beijing) BioPharmaceuticals Co., Ltd. and Qinghai Spring Medicinal Resources Technology Co., Ltd..